MedTrace Logo

Comparing Blood Sugar Levels and Endothelial Function of PEAK ATP® With GlycoCarn®, PEAK ATP® and GlycoCarn® Supplements

NCT01855373 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2016-04-15

No results posted yet for this study

Summary

To purpose of this study is to assess the effectiveness, safety and tolerability of PEAK ATP® with GlycoCarn®, PEAK ATP® and GlycoCarn® on levels of blood sugar and endothelial function improvement which may lead to improved vascular health.

Conditions

  • Blood Sugar
  • Endothelial Function

Interventions

DIETARY_SUPPLEMENT

PEAK ATP® with GlycoCarn®

PEAK ATP® with GlycoCarn® {Glycine Propionyl-L-Carnitine Hydrochloride, USP (500mg/capsule) and Adenosine 5'-Triphosphate Disodium Salt (100mg/capsule)}: 2 capsules twice daily on an empty stomach

DIETARY_SUPPLEMENT

PEAK ATP®

PEAK ATP® (Adenosine 5'-Triphosphate Disodium Salt (100mg/capsule): 2 capsules twice daily on an empty stomach

DIETARY_SUPPLEMENT

GlycoCarn®

GlycoCarn® (Glycine Propionyl-L-Carnitine Hydrochloride, USP (500mg/capsule): 2 capsules twice daily on an empty stomach

OTHER

Placebo

Placebo: 2 capsules twice daily on an empty stomach

Sponsors & Collaborators

  • Sigma Tau HealthScience LLC

    collaborator UNKNOWN

  • TSI Health Sciences, Inc.

    collaborator OTHER

  • Supplement Formulators, Inc.

    lead INDUSTRY

Principal Investigators

  • Steven Joyal, M.D. · Life Extension

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2016-03-31
Completion
2016-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01855373 on ClinicalTrials.gov